| Literature DB >> 25528664 |
Glenda Hawley1, Claire Jackson2, Julie Hepworth3, Shelley A Wilkinson4,5,6.
Abstract
BACKGROUND: Historically, the paper hand-held record (PHR) has been used for sharing information between hospital clinicians, general practitioners and pregnant women in a maternity shared-care environment. Recently in alignment with a National e-health agenda, an electronic health record (EHR) was introduced at an Australian tertiary maternity service to replace the PHR for collection and transfer of data. The aim of this study was to examine and compare the completeness of clinical data collected in a PHR and an EHR.Entities:
Mesh:
Year: 2014 PMID: 25528664 PMCID: PMC4302146 DOI: 10.1186/s12913-014-0650-x
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Description of grades of recommendations from Clinical Practice Guidelines Antenatal Care-Module 1. (8)
|
|
|
|---|---|
| Body of evidence can be trusted to guide practice | A |
| Body of evidence can be trusted to guide practice in most situations | B |
| Body of evidence provides some support for recommendation (s) but care should be taken in its application | C |
| Body of evidence is weak and recommendation must be applied with caution | D |
| Recommendation formulated in the absence of quality evidence (where a systematic review of the evidence was conducted as part of the search strategy) | CBR* |
| Area is beyond the scope of the systematic literature review and advice was developed by the EAC and/or the Working Group for Aboriginal and Torres Strait Islander Women’s Antenatal Care | PP** |
*CBR-recommendation formulated in the absence of quality evidence (where a systematic review of the evidence was conducted as part of the search strategy.
**PP-Area is beyond the scope of the systematic literature review and advice was developed by the EAC and/or the Working Group for Aboriginal and Torres Strait Islander Women’s Antenatal Care.
Specific best practice variables included in Phase 1 and Phase 2 from antenatal guidelines
|
|
|
|
|---|---|---|
|
| ||
| BMI (body mass index) |
|
|
| Blood pressure |
|
|
| Proteinuria |
|
|
|
| ||
| Blood group |
|
|
| Antibody status |
|
|
| Haemoglobin |
|
|
| Human immunodeficiency virus |
|
|
| Hepatitis B |
|
|
| Rubella |
|
|
| Syphilis |
|
|
| Urine culture (MSU) |
|
|
| GCT (glucose challenge test) |
|
|
| GTT (glucose tolerance test) |
|
|
|
| ||
| Dating scan |
|
|
| Nuchal scan |
|
|
| Morphology |
|
|
| Folic acid supplementation advice |
|
|
| Iron supplement advice |
|
|
| Use of vitamins in diet assessment |
|
|
| Iodine supplement advice |
|
|
| Vitamin D deficiency assessment |
|
|
| Oral health advice |
|
|
| Tobacco smoking |
|
|
| Alcohol assessment |
|
|
| Illicit drug use assessment |
|
|
| Domestic violence assessment |
|
|
| Mental health assessment (EDPS) |
|
|
|
| ||
| Pertussis |
|
|
| Hepatitis B |
|
|
| Varicella |
|
|
|
|
|
|
| Fluvax | ||
|
|
|
Description of best practice variables and timing of collection
|
|
|
|
|---|---|---|
|
| Measure weight and height and calculate body mass index (BMI). | At first antenatal visit |
|
| Measure blood pressure to identify existing high blood pressure. | At first antenatal visit |
|
| Use an automated analyser if available, or urinary dipstick as less accurate method to detect true proteinuria. | At first antenatal visit or subsequent visits |
|
| Important to prevent haemolytic disease of the newborn | At first antenatal visit |
|
| As above | At first antenatal visit |
|
| To assess anaemia | At first antenatal visit |
|
| Offer and recommend HIV testing | At first antenatal visit |
|
| Offer and recommend hepatitis B virus testing. | At first antenatal visit |
|
| Offer and recommend testing for rubella immunity | At first antenatal visit |
|
| Offer and recommend syphilis testing | At first antenatal visit |
|
| Use urine culture testing wherever possible as it is the most accurate means of detecting asymptomatic bacteriuria. | At first antenatal visit or subsequent visits |
| Glucose challenge test (GCT) | To screen for diabetes in pregnancy | Measured at 26–26 week visit |
|
| To screen for diabetes in pregnancy | Measured at 26–26 week visit |
|
| Offer an ultrasound scan to determine gestational age, detect multiple pregnancies and accurately time fetal anomaly screening. | between 8 weeks 0 days and 13 weeks 6 days |
|
| Offer nuchal translucency thickness ultrasound scan | Between 11 weeks 0 days and 13 weeks 6 days. |
|
| To check for abnormalities in your baby. | Scan at 18–20 week gestation |
|
| Inform women of/determine if dietary supplementation with folic acid, from 12 weeks before conception and throughout the first 12 weeks of pregnancy occurred | At first antenatal visit |
|
| Do not routinely offer iron supplementation to women during pregnancy. | At first antenatal visit |
|
| Offer vitamin D screening to women with limited exposure to sunlight, have dark skin or a pre-pregnancy BMI of >30. | At first antenatal visit |
|
| Advise/ask about oral health checks and treatment. | At first antenatal visit |
|
| Assess the woman’s smoking status and exposure to passive smoking. | At first antenatal visit |
|
| Advise women who are pregnant or planning a pregnancy that not drinking is the safest option. Discuss alcohol consumed during pregnancy. | At first antenatal visit |
|
| Determine if ever used illicit drugs or requires assistance. | At first antenatal visit |
|
| Explain to all women that asking about domestic violence is a routine part of antenatal care. | At first antenatal visit |
Figure 1Percentages of evidenced based best practice caribles between Phase 1 (PHR) and Phase 2 (EHR). ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05 for comparisons between PHR and EHR MSU-Midstream urine, EPDS–Edinburgh postnatal depression scale, PHR-Paper hand-held record, EHR-Electronic health record.